Cancer Cachexia Market, Industry Trends, Companies, Drugs and Analysis by DelveInsight

“Cancer Cachexia Market”

DelveInsight’s Cancer Cachexia market report thoroughly explains Cancer Cachexia, historical and forecasted epidemiology, and the Cancer Cachexia market trends in the 7MM. 

Key Highlights from the Cancer Cachexia Market Report

• Several secondary studies indicate that the overall incidence of cachexia is high and that it is increasing in industrialized countries such as North America, Europe, and Japan.

• According to a Japanese study titled “Cancer cachexia, mechanism and treatment” conducted by Aoyagi et al., cachexia occurs in most terminal cancer patients and is responsible for the death of 22% of cancer patients.

• Leading companies in the Cancer Cachexia market include Pfizer, Actimed Therapeutics, Incyte Corporation, Aveo Oncology, Extend Biosciences, and others.

• Key Cancer Cachexia therapies in the pipeline PF 06946860, ACM-001, Jakafi, AV-380, EXT418, and others.

• Actimed Therapeutics is currently developing ACM-001 (S-pindolol), formerly known as MT-102, which has completed a phase II trial (ACT-ONE) in patients with cachexia caused by stage III or IV non-small cell lung cancer (NSCLC) or colorectal cancer (CRC).

Have queries? Request for the sample @ Cancer Cachexia Market Outlook

Cancer Cachexia Overview

Cancer Cachexia is a wasting syndrome marked by weight loss, anorexia (loss of appetite), asthenia, and anemia. This syndrome’s pathogenicity is multifactorial due to a complex tumor and host factors interaction. Patients with advanced cancer, chronic obstructive pulmonary disease, chronic infection including AIDS and tuberculosis, chronic heart failure, and rheumatoid arthritis are at risk.

Cancer Cachexia Epidemiology Segmentation

The Cancer Cachexia report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into: 

• Cancer Cachexia Incident/Prevalent Cases 

• Cancer Cachexia Diagnosed Cases 

• Cancer Cachexia Treatable Cases 

Cancer Cachexia Treatment Landscape 

Currently, the potential treatment options available for cancer cachexia include Nutritional counseling or Appetite stimulants (Progestational agents, Ghrelin, Cannabinoids, and Corticosteroids), Cytokine-based therapeutic approaches, and Anabolic Steroids (non-steroidal selective androgen receptor modulator (SARM).

Cancer Cachexia Market Outlook

In the seven major markets, the total Cancer Cachexia market size will include the market size of both potential upcoming Cancer Cachexia therapies and current Cancer Cachexia treatment regimens.

Discover more about the future market share of the drugs @ Cancer Cachexia Market Analysis

Cancer Cachexia Pipeline Therapies and Key Companies

• PF 06946860: Pfizer

• ACM-001: Actimed Therapeutics

• Jakafi: Incyte Corporation

• AV-380: Aveo Oncology

• EXT418: Extend Biosciences

Table of Contents

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Cancer Anorexia Cachexia Syndrome (CACS) Market

DelveInsight’s “Cancer Anorexia-Cachexia Syndrome (CACS) – Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cancer Anorexia-Cachexia Syndrome (CACS), historical and forecasted epidemiology as well as the Cancer Anorexia-Cachexia Syndrome (CACS) market trends in the 7MM.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/